EMAIL THIS PAGE TO A FRIEND

Toxicology

Structural bisphenol analogues differentially target steroidogenesis in murine MA-10 Leydig cells as well as the glucocorticoid receptor.


PMID 25576683

Abstract

Although much information on the endocrine activity of bisphenol A (BPA) is available, a proper human hazard assessment of analogues that are believed to have a less harmful toxicity profile is lacking. Here the possible effects of BPA, bisphenol F (BPF), bisphenol S (BPS), as well as the brominated structural analogue and widely used flame retardant tetrabromobisphenol A (TBBPA) on human glucocorticoid and androgen receptor (GR and AR) activation were assessed. BPA, BPF, and TBBPA showed clear GR and AR antagonism with IC50 values of 67 μM, 60 μM, and 22 nM for GR, and 39 μM, 20 μM, and 982 nM for AR, respectively, whereas BPS did not affect receptor activity. In addition, murine MA-10 Leydig cells exposed to the bisphenol analogues were assessed for changes in secreted steroid hormone levels. Testicular steroidogenesis was altered by all bisphenol analogues tested. TBBPA effects were more directed towards the male end products and induced testosterone synthesis, while BPF and BPS predominantly increased the levels of progestagens that are formed in the beginning of the steroidogenic pathway. The MA-10 Leydig cell assay shows added value over the widely used H295R steroidogenesis assay because of its fetal-like characteristics and specificity for the physiologically more relevant testicular Δ4 steroidogenic pathway. Therefore, adding an in vitro assay covering fetal testicular steroidogenesis, such as the MA-10 cell line, to the panel of tests used to screen potential endocrine disruptors, is highly recommendable.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

11223
3,3′,5,5′-Tetrabromobisphenol A, analytical standard
C15H12Br4O2
330396
3,3′,5,5′-Tetrabromobisphenol A, 97%
C15H12Br4O2
442840
4,4′-Isopropylidenediphenol, analytical standard
C15H16O2
103039
4,4′-Sulfonyldiphenol, 98%
C12H10O4S
B47006
Bis(4-hydroxyphenyl)methane, 98%
C13H12O2
239658
Bisphenol A, ≥99%
C15H16O2
42088
Bisphenol A, certified reference material, TraceCERT®
C15H16O2
133027
Bisphenol A, 97%
C15H16O2
H6132
DL-3-Hydroxy-3-methylglutaryl coenzyme A sodium salt hydrate, ≥90% (HPLC)
C27H42N7Na2O20P3S · xH2O
L8912
L-Leucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
C6H13NO2
L8000
L-Leucine, reagent grade, ≥98% (HPLC)
C6H13NO2
L6914
L-Leucine, PharmaGrade, Ajinomoto, EP, JP, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture
C6H13NO2
61819
L-Leucine, BioUltra, ≥99.5% (NT)
C6H13NO2
76526
L-Leucine, certified reference material, TraceCERT®
C6H13NO2
W329703
L-Leucine, 99%, FG
C6H13NO2
1357001
L-Leucine, United States Pharmacopeia (USP) Reference Standard
C6H13NO2
PHR1105
L-Leucine, Pharmaceutical Secondary Standard; Certified Reference Material
C6H13NO2
L0375000
Leucine, European Pharmacopoeia (EP) Reference Standard
C6H13NO2